Varicella-Zoster Vaccine (Zoster, Live Attenuated)
Indications
Registered South African indications:
- Immunisation against herpes zoster
- Prevention of post-herpetic neuralgia
Cautions
Contraindications
- Hypersensitivity to the active ingredient or any of its excipients
- Hypersensitivity to neomycin
- Pregnancy
- Primary and acquired immunodeficiency states due to conditions such as
- Acute and chronic leukaemia's
- Lymphoma
- Other conditions affecting the bone marrow or lymphatic system
- Immunosuppression due to HIV/AIDS
- Cellular immune deficiencies - Immunosuppressive therapy (including high-dose corticosteroids); however, varicella-zoster vaccine is not contraindicated for use in individuals who are receiving topical/inhaled corticosteroids or low-dose systemic corticosteroids or in patients who are receiving corticosteroids as replacement therapy, e.g., for adrenal insufficiency
- Active, untreated tuberculosis
Cautions
- Breastfeeding
- Severe thrombocytopenia
- Coagulation disorder
- Moderate to severe acute febrile illness or infection
Adult dosage
Forms avail. in SA and covered in this monograph: inj
Prevention of herpes zoster
- For immunization of individuals older than 50 years
Prevention of herpes zoster-related post-herpetic neuralgia
- For immunization of individuals older than 50 years
- SC: 0.65ml, as a single dose
Paediatric dosage
Not established for use in children
Special populations
Pregnancy
- Contraindicated
Breastfeeding
Renal Impairment
Hepatic Impairment
Elderly
Adverse reactions
Central Nervous System Disorders
- Headache
Gastrointestinal Disorders
- Nausea
Musculoskeletal Disorders
- Arthralgia
- Myalgia
- Pain in extremity
Skin and Subcutaneous Tissue Disorders
- Varicella
- Herpes zoster
- Rash
- Injection site reactions
Immune, Blood and Lymphatic System Disorders
- Lymphadenopathy
- Hypersensitivity reactions
- Anaphylaxis
Sensory Disorders
- Necrotizing retinitis
Interactions
- Pneumococcal polysaccharide vaccine
- Antiviral agents
Monitoring
None routine
Mechanism of action
The live, attentuated varicella-zoster vaccine stimulates the production of antibodies to the varicella-zoster virus.
Dosage forms
- Injection
Formulation
Injection (per 0.65ml) 19400pfu
- Zostavax (MSD) originator
References
1. SAMF_12th Edition_Page 368 2. https://www.medicines.org.uk/emc/medicine/25927 (01/03/2017_Merck_Zostavax_inj) 3. https://drive.google.com/drive/folders/0B27NqM_vidrmT0hoMjVvM20ydzg (06/08/2015_MSD_Zostavax_inj) 4. https://www.uptodate.com/contents/zoster-vaccine-drug-information?source=preview&search=herpes%20zoster%20vaccine&anchor=F2985447#F2985447 5. https://www.drugs.com/pregnancy/zoster-vaccine-live.html
Brands & products
1 product · cached snapshot- Zostavax
INJInjection· 1 product
from R2094.36| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Zostavax | 19400 pfu/0.65ml | 0.65 | MSD (Pty) Ltd | R2094.36 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.